Optimized transduction of human monocyte-derived dendritic cells by recombinant adeno-associated virus serotype 6

Human Gene Therapy

Volumn 21, Issue 12, 2010, Pages 1675-1686

  Ussher, James E ^a   Taylor, John A ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; LYSINE; PARVOVIRUS VECTOR; TYROSINE;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS TYPE 2; ADENO ASSOCIATED VIRUS TYPE 6; AMINO ACID SUBSTITUTION; ARTICLE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PHENOTYPIC VARIATION; PROCESS OPTIMIZATION; PROTEIN PHOSPHORYLATION; SEROTYPE; UBIQUITINATION; VIRUS CAPSID; VIRUS MUTATION; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; CAPSID PROTEINS; CELL DIFFERENTIATION; DENDRITIC CELLS; DEPENDOVIRUS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPHENOTYPING; MOLECULAR SEQUENCE DATA; MONOCYTES; MUTAGENESIS, SITE-DIRECTED; MUTATION; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SEROTYPING; TRANSDUCTION, GENETIC; VIRAL LOAD; VIRAL TROPISM;

ADENO-ASSOCIATED VIRUS; MIRIDAE;

EID: 78650082356     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.087     Document Type: Article

References (47)

1. Aldrich, W.A., Ren, C., White, A.F., Zhou, S.-Z., Kumar, S., Jenkins, C.B., Shaw, D.R., Strong, T.V., Triozzi, P.L., and Ponnazhagan, S. (2006). Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands. Gene Ther. 13, 29-39. (Pubitemid 41823849)
2. Aucoin, M.G., Perrier, M., and Kamen, A.A. (2008). Critical assessment of current adeno-associated viral vector production and quantification methods. Biotechnol. Adv. 26, 73-88. (Pubitemid 350148247)
3. Banchereau, J., and Steinman, R.M. (1998). Dendritic cells and the control of immunity. Nature 392, 245-252. (Pubitemid 28155090)
4. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., and Palucka, K. (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811. (Pubitemid 30365397)
5. Cao, C., Lu, S., Jiang, Q., Wang, W., Song, X., Kivlin, R., Wallin, B., Bagdasarian, A., Tamakloe, T., and Chu, W. (2008). EGFR activation confers protections against UV-induced apopto-sis in cultured mouse skin dendritic cells. Cell. Signal. 20, 1830-1838.
6. Cheng, C., Gall, J.G.D., Kong, W.-P., Sheets, R.L., Gomez, P.L., King, C.R., and Nabel, G.J. (2007). Mechanism of Ad5 vaccine immunity and toxicity: Fiber shaft targeting of dendritic cells. PLoS Pathog. 3, e25.
7. \+ T cells. J. Immunol. 162, 3256-3262. (Pubitemid 29313572)
8. Dong, J.-Y., Fan, P.-D., and Frizzell, R.A. (1996). Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7, 2101-2112. (Pubitemid 26400735)
9. During, M.J., Young, D., Baer, K., Lawlor, P., and Klugmann, M. (2003). Development and optimization of adeno-associated virus vector transfer into the central nervous system. Methods Mol. Med. 76, 221-236.
10. Figdor, C.G., De Vries, I.J.M., Lesterhuis, W.J., and Melief, C.J.M. (2004). Dendritic cell immunotherapy: Mapping the way. Nat. Med. 10, 475-480. (Pubitemid 38667904)
11. Gao, G., Vandenberghe, L.H., and Wilson, J.M. (2005). New recombinant serotypes of AAV vectors. Curr. Gene Ther. 5, 285-297. (Pubitemid 40895013)
12. Gehring, A.J., Sun, D., Kennedy, P.T.F., Nolte-'T Hoen, E., Lim, S.G., Wasser, S., Selden, C., Maini, M.K., Davis, D.M., Nassal, M., and Bertoletti, A. (2007). The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J. Virol. 81, 2940-2949. (Pubitemid 46447057)
13. Grieger, J.C., Choi, V.W., and Samulski, R.J. (2006). Production and characterization of adeno-associated viral vectors. Nat. Protoc. 1, 1412-1428.
14. Halbert, C.L., Allen, J.M., and Miller, A.D. (2001). Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared with that of AAV2 vectors. J. Virol. 75, 6615-6624. (Pubitemid 32578181)
15. 500-585. J. Immunol. 174, 4516-4524.
16. Harrop, J.S., Poulsen, D.J., Xiao, W., Freese, A., and During, M.J. (2004). Effect of altering titer, serotype, and promoter in re-combinant adeno-associate virus gene therapy expression of spinal cord neurons and astrocytes. Spine 29, 2787-2792.
17. Hermens, W.T.J.M.C., Ter Brake, O., Dijkhuizen, P.A., Sonne-mans, M.A.F., Grimm, D., Kleinschmidt, J.A., and Verhaagen, J. (1999). Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system. Hum. Gene Ther. 10, 1885-1891. (Pubitemid 29357694)
18. Jayandharan, G., Rivers, A.E., Ling, C., Andino, L., Zhong, L., and Srivastava, A. (2009). Human hematopoietic stem cell transduction by AAV vectors: Identification of AAV6 as the most efficient serotype, and further augmentation in trans-duction efficiency with point-mutations at tyrosine residues 705 and 731 in the viral capsid. Mol. Ther. 17, S145-S146.
19. Johnson, P.R., Schnepp, B.C., Connell, M.J., Rohne, D., Robinson, S., Krivulka, G.R., Lord, C.I., Zinn, R., Montefiori, D.C., Letvin, N.L., and Clark, K.R. (2005). Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques. J. Virol. 79, 955-965. (Pubitemid 40053879)
20. Liu, Y., Santin, A.D., Mane, M., Chiriva-Internati, M., Parham, G.P., Ravaggi, A., and Hermonat, P.L. (2000). Transduction and utility of the granulocyte-macrophage colony-stimulating factor gene into monocytes and dendritic cells by adeno-associated virus. J. Interferon Cytokine Res. 20, 21-30. (Pubitemid 30067486)
21. Luk, K.D.K., Chen, Y., Cheung, K.M.C., Kung, H.-F., Lu, W.W., and Leong, J.C.Y. (2003). Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation. Biochem. Biophys. Res. Commun. 308, 636-645. (Pubitemid 36945540)
22. McCaffrey, A.P., Fawcett, P., Nakai, H., McCaffrey, R.L., Ehr-hardt, A., Pham, T.-T.T., Pandey, K., Xu, H., Feuss, S., Storm, T.A., and Kay, M.A. (2008). The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver. Mol. Ther. 16, 931-941. (Pubitemid 351587104)
23. \+ T cells. Immunol. Rev. 211, 81-92. (Pubitemid 43882963)
24. Mouravlev, A., Young, D., and During, M.J. (2007). Phosphor-ylation- dependent degradation of transgenic CREB protein initiated by heterodimerization. Brain Res. 1130, 31-37. (Pubitemid 46053890)
25. Ponnazhagan, S., Mahendra, G., Curiel, D.T., and Shaw, D.R. (2001). Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: Implications for ex vivo immunotherapy. J. Virol. 75, 9493-9501. (Pubitemid 32851951)
26. Reed, S.E., Staley, E.M., Mayginnes, J.P., Pintel, D.J., and Tullis, G.E. (2006). Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors. J. Virol. Methods 138, 85-98. (Pubitemid 44633451)
27. Rutledge, E.A., Halbert, C.L., and Russell, D.W. (1998). Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72, 309-319. (Pubitemid 28048842)
28. Schmidt, M., Voutetakis, A., Afione, S., Zheng, C., Mandikian, D., and Chiorini, J.A. (2008). Adeno-associated virus type 12 (AAV12): A novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity. J. Virol. 82, 1399-1406.
29. Shin, O., Kim, S.J., Lee, W.I., Kim, J.Y., and Lee, H. (2008). Effective transduction by self-complementary adeno-associated viruses of human dendritic cells with no alteration of their natural characteristics. J. Gene Med. 10, 762-769. (Pubitemid 352003919)
30. Smith, C.L., Mirza, F., Pasquetto, V., Tscharke, D.C., Palmowski, M.J., Dunbar, P.R., Sette, A., Harris, A.L., and Cerundolo, V. (2005). Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara. J. Immunol. 175, 8431-8437. (Pubitemid 41798411)
31. Smith, R.H. (2008). Adeno-associated virus integration: Virus versus vector. Gene Ther. 15, 817-822. (Pubitemid 351712614)
32. Steinman, R.M., and Nussenzweig, M.C. (2002). Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. U.S.A. 99, 351-358. (Pubitemid 34060366)
33. Tillman, B.W., Gruijl, T.D., Bakker, S.A., Scheper, R.J., Pinedo, H.M., Curiel, T.J., Gerritsen, W.R., and Curiel, D.T. (1999). Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J. Immunol. 162, 6378-6383. (Pubitemid 29309357)
34. Vandenberghe, L.H., Wang, L., Somanathan, S., Zhi, Y., Fig-ueredo, J., Calcedo, R., Sanmiguel, J., Desai, R.A., Chen, C.S., Johnston, J., Grant, R.L., Gao, G., and Wilson, J.M. (2006). Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Nat. Med. 12, 967-971. (Pubitemid 44175151)
35. Veron, P., Allo, V., Riviere, C., Bernard, J., Douar, A.-M., and Masurier, C. (2007). Major subsets of human dendritic cells are efficiently transduced by self-complementary adeno-associated virus vectors 1 and 2. J. Virol. 81, 5385-5394. (Pubitemid 46744447)
36. Wang, L., Wang, C.J., Tan, C.Y., Hsu, D., and Hennessey, J.P. (2006). A robust approach for the quantitation of viral concentration in an adenoviral vector-based human immunodeficiency virus vaccine by real-time quantitative poly-merase chain reaction. Hum. Gene Ther. 17, 728-740. (Pubitemid 44100718)
37. Weller, M.L., Amornphimoltham, P., Schmidt, M., Wilson, P.A., Gutkind, J.S., and Chiorini, J.A. (2010). Epidermal growth factor receptor is a co-receptor for adeno-associated virus se-rotype 6. Nat. Med. 16, 662-664.
38. Wu, Z., Asokan, A., Grieger, J.C., Govindasamy, L., Agbandje-McKenna, M., and Samulski, R.J. (2006a). Single amino acid changes can influence titer, heparin binding, and tissue tro-pism in different adeno-associated virus serotypes. J. Virol. 80, 11393-11397. (Pubitemid 44706580)
39. Wu, Z., Asokan, A., and Samulski, R.J. (2006b). Adeno-associ-ated virus serotypes: Vector toolkit for human gene therapy. Mol. Ther. 14, 316-327. (Pubitemid 44184972)
40. Xiao, W., Chirmule, N., Berta, S.C., McCullough, B., Gao, G., and Wilson, J.M. (1999). Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73, 3994-4003. (Pubitemid 29189844)
41. Xin, K.-Q., Mizukami, H., Urabe, M., Toda, Y., Shinoda, K., Yoshida, A., Oomura, K., Kojima, Y., Ichino, M., Klinman, D., Ozawa, K., and Okuda, K. (2006). Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells. J. Virol. 80, 11899-11910. (Pubitemid 44904340)
42. You, H., Liu, Y., Cong, M., Ping, W., You, C., Zhang, D., Mehta, J.L., and Hermonat, P.L. (2006). HBV genes induce cytotoxic T-lymphocyte response upon adeno-associated virus (AAV) vector delivery into dendritic cells. J. Viral Hepat. 13, 605-612. (Pubitemid 44232544)
43. Young, L.J., Wilson, N.S., Schnorrer, P., Mount, A., Lundie, R.J., La Gruta, N.L., Crabb, B.S., Belz, G.T., Heath, W.R., and Vil-ladangos, J.A. (2007). Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. Proc. Natl. Acad. Sci. U.S.A. 104, 17753-17758. (Pubitemid 350210907)
44. Zaiss, A.-K., Liu, Q., Bowen, G.P., Wong, N.C.W., Bartlett, J.S., and Muruve, D.A. (2002). Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J. Virol. 76, 4580-4590. (Pubitemid 34309593)
45. Zhong, L., Li, B., Mah, C.S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R.W., Zolotukhin, I., Warrington, K.H., Weigel-Van Aken, K.A., Hobbs, J.A., Zo-lotukhin, S., Muzyczka, N., and Srivastava, A. (2008). Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc. Natl. Acad. Sci. U.S.A. 105, 7827-7832. (Pubitemid 351872723)
46. Zhong, L., Li, B., Li, M., Zolotukhin, I., Herzog, R.W., Zolotu-khin, S., and Srivastava, A. (2009). High-efficiency transduc-tion of human cells in vitro and murine hepatocytes in vivo at further reduced doses of AAV2 vectors containing multiple-mutations in surface-exposed tyrosine residues in the viral capsid. Mol. Ther. 17, S145.
47. Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y., Loiler, S., Fraites, T.J., Chiodo, V.A., Phillipsberg, T., Muzyczka, N., Hauswirth, W.W., Flotte, T.R., Byrne, B.J., and Snyder, R.O. (2002). Production and purification of serotype 1, 2, and 5 re-combinant adeno-associated viral vectors. Methods 28, 158-167. (Pubitemid 35341079)